Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.Donate to our crowdfunder
Mark Tami: The hon. Gentleman talks about recorded cases, but does he accept that in their normal line of duty, there is an acceptance that police officers are roughed up and pushed around? Much of that is not even taken into account.
Mark Tami: On the British Steel pension scheme, does the hon. Gentleman agree that the FCA has been very slow to react, when it was clear in certain locations that there were many problems with the way some people were advising people to get out of the scheme?
Mark Tami: The hon. Gentleman keeps saying that this is about releasing equity. What people are actually doing is borrowing against the perceived wealth of the property.
Mark Tami: To ask the Secretary of State for Health and Social Care, what meetings he has had with representatives of blood cancer patients to discuss the availability of treatment options on the NHS for patients diagnosed with relapsed acute lymphoblastic leukaemia.
Mark Tami: To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of the adequacy of the availability of treatment options for patients with relapsed acute lymphoblastic leukaemia in the (a) UK and (b) EU countries.
Mark Tami: To ask the Secretary of State for Health and Social Care, what assessment he has made of (a) the accuracy of NICE's calculation of the wider value of (i) rare disease and (ii) rarer cancer treatments and (b) the extent to which NICE accounts in that calculation for (A) additional medical benefits, (B) wider economic consequences and (C) social impact costs.
Mark Tami: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 December 2017 to Question 119731 on Pneumoccocol Diseases: Vaccination, whether NHS England is responsible for funding the vaccination of adults who have undergone stem cell transplantation under paragraph 4.2 of the NHS public health functions agreement 2017-18: Service specification no.8 Pneumococcal...
Mark Tami: My hon. Friend mentioned removal of mesh. Does he agree that there should have been a lot more research about how easy it is to remove, because it is actually very difficult and only a few surgeons will undertake that work?
Mark Tami: Does the hon. Lady agree that many women were told that this was like a miracle cure—a very quick fix—and were not given all the facts about it?
Mark Tami: Is my hon. Friend as alarmed as I am—she clearly is—that today and tomorrow women will be having operations that might well cause them complications in the future? Does she agree that these operations should be stopped until we find out the truth?
Mark Tami: My hon. Friend mentioned women feeling that they were alone, which is one of the main problems. I have spoken to a lot of people who were told that there was not a problem and that they were perhaps the only ones experiencing a problem. People were on a host of painkillers and were not told that others had experienced the same and that it was a much wider problem.
Mark Tami: The Secretary of State is talking about the long term, which is very important. For a company such as Airbus, the relationship with its suppliers, which is not a short-term relationship but a long-term one, is also very important. It is because such a relationship is so important that there are fears about how long Melrose will actually invest in GKN and keep hold of that company.
Mark Tami: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 27 February to Question 128018, on Clinical Priorities Advisory Group, on what date NHS England plans to announce (a) announce the results of the prioritisation process and (b) make funding available for approved medicines policies.
Mark Tami: To ask the Secretary of State for Health and Social Care, what process was used to forecast budgetary need in order to determine the £25 million annual budget allocation for products undergoing review by the NHS England specialised commissioning prioritisation process.
Mark Tami: To ask the Secretary of State for Health and Social Care, what the (a) annual budget, (b) total annual expenditure and (c) rationale for how budget allocations were arrived at was for products reviewed by the NHS England specialised commissioning prioritisation process for the last three years for which figures are available.
Mark Tami: Does my hon. Friend agree that another crucial time is when someone moves from children’s services to adult services? That can be a very traumatic period if it is not handled properly.
Mark Tami: Does the right hon. Lady agree that the situation is also very frustrating for those who fail to get a diagnosis of autism, particularly when their local authority is not able to provide one, or says that it does not have the resources to do so? Even if a person pays privately for one, the local authority will not accept that as a diagnosis.
Mark Tami: My hon. Friend mentioned right to buy. Some of the right-to-buy houses that were originally bought by their renters have now been sold on, often to landlords. Some of those properties are not in the best of care and on many estates they are the ones that really stick out, often because rogue landlords are not looking after them.
Mark Tami: Further to that point, the Countess of Chester hospital was built to serve Chester and Deeside, yet I cannot have any view about it, despite the fact that a large number of people from Wales will attend that hospital.
Mark Tami: Clearly the Toyota announcement was extremely good news, but it was planned over a number of years. Does the Secretary of State agree that the company, along with others such as Airbus, has major concerns about the post-Brexit situation, particularly if we have tariffs?